BD launches new benchtop cell analyzer

By Melissa Busch, The Science Advisory Board contributing writer

August 11, 2021 -- Medical technology company Becton Dickinson (BD) has launched a new benchtop cell analyzer called FACSymphony A1 that offers new capabilities in flow cytometry instrumentation to scientific research labs of all sizes.

The FACSymphony A1 cell analyzer is compact enough to be used in small labs with limited space, and it allows larger labs to perform exploratory experiments without tying up freestanding cell analyzers that may be needed for more complex experiments with longer lead times, according to the company.

The new BD FACSymphony A1 cell analyzer
The new BD FACSymphony A1 cell analyzer brings new flow cytometry capabilities to laboratories of all sizes.

Using fluorescence-activated cell sorter (FACS) technology, the analyzer can precisely isolate selected single cells from complex samples. Also, it is flexible enough to be used in many types of research, including small-particle studies and 16-color immunophenotyping.

FACSymphony A1 confers benefits to scientists and researchers alike, who can use the cell analyzer to conduct a variety of flow cytometry experiments, according to BD.

"We know from our customers that research time and resource allocation are critically important factors in determining the most appropriate cell analyzer to perform their work," said Puneet Sarin, worldwide president of BD Biosciences, in a release issued by the company.

Antheia nabs $73M for synthetic biology platform
Antheia has raised $73 million to support the commercialization of its first pharmaceutical compound and the scale-up of production of active pharmaceutical...
BD posts healthy global, U.S. Q4 revenues
Becton Dickinson (BD) has reported worldwide fourth quarter revenues of $4.8 billion, up 4.4% compared to the same period in 2019. U.S. revenues...
BD names new executive vice presidents
Becton Dickinson (BD) has appointed Patrick Kaltenbach as executive vice president and chief technology officer. The firm also promoted Dave Hickey to...
BD granted FDA clearance for sample preparation system
Becton Dickinson (BD) announced that it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for an integrated sample preparation...
BD to provide injection devices for mass doses of COVID-19 vaccines
Becton Dickinson (BD) formed a strategic partnership with the Biomedical Advanced Research and Development Authority to develop new manufacturing lines...

Copyright © 2021 scienceboard.net


Conferences
Building Biology in 3D Hybrid Symposium
October 26-27
La Jolla, California United States
Northeast Regional Laboratory Staff and Core Directors (NERLSCD) 2021
November 3-5
Portsmouth, New Hampshire United States
CPhI Worldwide 2021
November 9-11
Milan, Lombardia Italy
Society for Immunotherapy of Cancer (SITC) Annual Meeting
November 10-14
Washington, DC, District of Columbia United States
Connect
Science Advisory Board on LinkedIn
Science Advisory Board on Facebook
Science Advisory Board on Twitter